SWM
TRIB

Spire Wealth Management’s Trinity Biotech TRIB Stock Holding History

Spire Wealth Management’s Portfolio TRIB Stock Details TRIB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q4 		– Sell
-100
Closed -$1K – 3005
2021
Q3 		$1K Hold
100
– – ﹤0.01% 2548
2021
Q2 		$1K Hold
100
– – ﹤0.01% 2551
2021
Q1 		$2K Buy
+100
New +$2.4K ﹤0.01% 2888

Other funds holding TRIB

HAIM
Hunter Associates Investment Management Pittsburgh, Pennsylvania $756M AUM 19.99% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
SCM
Stonehill Capital Management New York $197M AUM 96.45% 1-Year Est. Return
Envestnet Asset Management
Envestnet Asset Management Chicago, Illinois $374B AUM 17.66% 1-Year Est. Return
LPL Financial
LPL Financial San Diego, California $377B AUM 19.32% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
WCM
Whitefort Capital Management New York $339M AUM 52.48% 1-Year Est. Return
WP
WealthSource Partners San Luis Obispo, California $1.54B AUM 16.68% 1-Year Est. Return

Spire Wealth Management's TRIB Position: Q4 2021 in Review

Spire Wealth Management sold out of Trinity Biotech (TRIB) in Q4 2021, closing a stake of 100 shares — an estimated $1K sold.

Spire Wealth Management first reported a position in TRIB in Q1 2021 and held it in 3 quarters. The position peaked at $2K in Q1 2021. 21 funds tracked by Wall St. Rank hold TRIB as of Q4 2021.

  • Spire Wealth Management reported no remaining Trinity Biotech position as of Q4 2021 after selling out during the quarter.
  • Spire Wealth Management sold 100 Trinity Biotech shares in Q4 2021, an estimated $1K.
  • Spire Wealth Management first reported a position in Trinity Biotech in Q1 2021 and held it in 3 quarters.
  • Spire Wealth Management's Trinity Biotech position peaked at $2K in Q1 2021.
  • 21 funds tracked by Wall St. Rank held Trinity Biotech as of Q4 2021.

Based on Spire Wealth Management's 13F filing for Q4 2021, filed 14 Jan 2022.